Regulation of RASSF1A in nasopharyngeal cells and its response to UV irradiation

Gene

Volumn 443, Issue 1-2, 2009, Pages 55-63

  Lee, Vien H Y ^a   Chow, Billy K C ^a   Lo, K W ^b   Chow, Lillian S N ^b   Man, Cornelia ^a   Tsao, S W ^a   Lee, Leo T O ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Nasopharyngeal carcinoma; Promoter; Ras Association Domain Family 1 A (RASSF1A); Sp proteins

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NASOPHARYNX CANCER; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION;

CELL LINE, TUMOR; CPG ISLANDS; DOWN-REGULATION; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 4; MUTAGENESIS, SITE-DIRECTED; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS, GENETIC; SP TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; ULTRAVIOLET RAYS;

EID: 67449099848     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2009.05.003     Document Type: Article

References (48)

1. Assefa Z., Van Laethem A., Garmyn M., and Agostinis P. Ultraviolet radiation-induced apoptosis in keratinocytes: on the role of cytosolic factors. Biochim. Biophys. Acta. 1755 (2005) 90-106
2. Bender K., Gottlicher M., Whiteside S., Rahmsdorf H.J., and Herrlich P. Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV. EMBO J. 17 (1998) 5170-5181
3. Chen W., Borchers A.H., Dong Z., Powell M.B., and Bowden G.T. UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratinocyte cell line. J. Biol. Chem. 273 (1998) 32176-32181
4. Chen Y., et al. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. J. Proteome Res. 7 (2008) 5254-5262
5. Cheng C.K., Yeung C.M., Chow B.K., and Leung P.C. Characterization of a new upstream GnRH receptor promoter in human ovarian granulose-luteal cells. Mol. Endocrinol. 16 (2002) 1552-1564
6. Cheung S.T., et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 83 (1999) 121-126
7. Chow B.K., et al. Structural-functional studies of human transferrin by using in vitro mutagenesis. Curr. Stud. Hematol. Blood Transfus. 58 (1991) 132-138
8. Chow L.S., et al. Identification of RASSF1A modulated genes in nasopharyngeal carcinoma. Oncogene 25 (2006) 310-316
9. Chu S., and Ferro T.J. Identification of a hydrogen peroxide-induced PP1-JNK1-Sp1 signaling pathway for gene regulation. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (2006) 983-992
10. Cooper S., Ranger-Moore J., and Bowden T.G. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain. Mol. Carcinog. 43 (2005) 108-116
11. Dammann R., Li C., Yoon J.H., Chin P.L., Bates S., and Pfeifer G.P. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat. Genet. 25 (2000) 315-319
12. Deng C., et al. Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum. 44 (2001) 397-407
13. Derijard B., et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76 (1994) 1025-1037
14. Donninger H., Vos M.D., and Clark G.J. The RASSF1A tumor suppressor. J. Cell Sci. 120 (2005) 3163-3172
15. Ghosh R., and Mitchell D.L. Effect of oxidative DNA damage in promoter elements on transcription factor binding. Nucleic Acids Res. 27 (1999) 3213-3218
16. Ghosh R., Amstad P., and Cerutti P. UVB-induced DNA breaks interfere with transcriptional induction of c-fos. Mol. Cell Biol. 13 (1993) 6992-6999
17. Hori Y., Kiyoshima K., Yamada Y., Nakashima Y., Naito S., and Tsuneyochi M. Oxidative stress and DNA hypermethylation status in renal cell carcinoma arising in patients on dialysis. J. Pathol. 212 (2007) 218-226
18. Huang D.P., et al. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int. J. Cancer 26 (1980) 127-132
19. Jackson S.P., MacDonald J.J., Lees-Miller S., and Tjian R. GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 63 (1990) 155-165
20. Kaina B. DNA damage-triggered apoptosis: critical role of DNA repair, double-strand breaks, cell proliferation and signaling. Biochem. Pharmacol. 66 (2003) 1547-1554
21. Kambe A., Iguchi G., Moon Y., Kamitani H., Watanabe T., and Eling T.E. Regulation of EP4 expression via the Sp-1 transcription factor: inhibition of expression by anti-cancer agents. Biochim. Biophys. Acta 1783 (2008) 1211-1219
22. Koitabashi N., et al. Carvedilol effectively blocks oxidative stress-mediated downregulation of sarcoplasmic reticulum Ca2+-ATPase 2 gene transcription through modification of Sp1 binding. Biochem. Biophys. Res. Commun. 328 (2005) 116-124
23. Kwong J., Lo K.W., To K.F., Teo P.M., Johnson P.J., and Huang D.P. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res. 8 (2002) 131-137
24. Lee K.A., Bindereif A., and Gottlicher M. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech. 5 (1988) 22-31
25. Lee L.T., Tan-Un K.C., Pang R.T., Lam D.T., and Chow B.K. Regulation of the human secretin gene is controlled by the combined effects of CpG methylation, Sp1/Sp3 ratio, and the E-box element. Mol. Endocrinol. 18 (2004) 1740-1755
26. Lee L.T., Tan-Un K.C., Lin M.C., and Chow B.K. Retinoic acid activates human secretin gene expression by Sp proteins and nuclear factor I in neuronal SH-SY5Y cells. J. Neurochem. 93 (2005) 339-350
27. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
28. Lo K.W., et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res. 61 (2001) 3877-3881
29. Lu R., Chen F.C., Sun D.F., Tian X.Q., and Fang J.Y. Inhibition of the extracellular signal-regulated kinase/mitogen-activation protein kinase pathway decreases DNA methylation in colon cancer cells. J. Biol. Chem. 282 (2007) 1249-1259
30. Lund P., et al. Oncogenic HRAS suppresses clusterin expression through promoter hypermethylation. Oncogene 25 (2006) 4890-4903
31. Man C., et al. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells. Oncogene 26 (2007) 3069-3080
32. Milanini-Mongiat J., Pouyssegur J., and Pages G. Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinase: their implication in vascular endothelial growth factor gene transcription. J. Biol. Chem. 277 (2002) 20631-20639
33. Misawa J., et al. RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker. Br. J. Cancer 100 (2009) 399-404
34. Nelson R.M., and Long G. A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction. Anal. Biochem. 180 (1989) 147-151
35. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 94 (2001) 153-156
36. Puente S., et al. Metastic small cell carcinoma to the thyroid gland: a pathologic and molecular study demonstrating the origin in the urinary bladder. Endocr. Pathol. 19 (2008) 190-196
37. Ramirez T., Garcia-Montalvo V., Wise C., Cea-Olivares R., Poirier L.A., and Herrera L.A. S-adenosyl-l-methionine is able to reverse micronucleus formation induced by sodium arsenite and other cytoskeleton disrupting agents in cultured human cells. Mutat. Res. 528 (2003) 61-74
38. Rong R., Jin W., Zhang J., Sheikh M.S., and Huang Y. Tumor suppressor RASSF1A is a microtubule-binding protein that stabilizes microtubules and induces G2/M arrest. Oncogene 23 (2004) 8216-8230
39. Sathyanarayana U.G., et al. Sun exposure related methylation in malignant skin lesions. Cancer Lett. 245 (2007) 112-120
40. Schäfer G., Cramer T., Suske G., Kemmner W., Wiedenmann B., and Höcker M. Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements. J. Biol. Chem. 278 (2003) 8190-8198
41. Shivakumar L., Minna J., Sakamaki T., Pestell R., and White M.A. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol. Cell. Biol. 22 (2002) 4309-4318
42. Simbulan-Rosenthal C.M., et al. Id2 protein is selectively upregulated by UVB in primary, but not in immortalized human keratinocytes and inhibits differentiation. Oncogene 24 (2005) 5443-5458
43. Tsao S.W., et al. Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. Biochim. Biophys. Acta. 1590 (2002) 150-158
44. Vichalkovski A., Gresko E., Cornil H., Hergovich A., Schmitz D., and Hemmings B.A. NDR kinase is activated by RASSF1A/MST1 in response to Fas receptor stimulation and promotes apoptosis. Curr. Biol. 18 (2008) 1889-1895
45. Wang X., Sun D.F., Chen Z.F., Chen Y.X., and Fang J.Y. RAF may induce cell proliferation through hypermethylation of tumor suppressor gene promoter in gastric epithelial cells. Cancer Sci. 100 (2008) 117-125
46. 1/S phase transition to promote cell cycle progression in human epithelial cells. Mol. Cell Biol. 28 (2008) 3190-3197
47. Yu M.C., and Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 12 (2002) 421-429
48. Zhu W.G., et al. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol. Cell Biol. 23 (2003) 4056-4065